[1] |
ZHU Yuanchao, ZHANG Yatong, HU Xin.
Principles and measures of medication risk management in the elderly
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1031-1034.
|
[2] |
HUANG Cuili, GAO Ao, WANG Jiaxi, GUO Haili, XU Xiaohan, CHENG Yinchu, GUO Daihong.
Automatic monitoring and assessment of antibiotics-related thrombocytopenia
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 807-811.
|
[3] |
ZHU Yuanchao, ZHAO Ming, HU Xin, SHI Hong.
Pharmacist-led practice in the management of elderly patients with polypharmacy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 817-821.
|
[4] |
ZHANG Qingxia, ZHOU Liujun, LI Xiaoling, WANG Yuqin.
Cefoperazone/sulbactam-related medication errors in the elderly and countermeasures
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 574-578.
|
[5] |
HUANG Shaolan, YANG Ge, LI Wei.
One case of muscle loss induced by ceftazidime-avibactam for injection combined with polymyxins B sulfate for injection after renal transplantation
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 583-584.
|
[6] |
ZHANG Yuan, HE Mei.
Pharmaceutical care for a case of Parkinson's syndrome caused by trimetazidine hydrochloride tablets in an elderly patient with renal insufficiency
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 343-345.
|
[7] |
WANG Yu, HUANG Jingyi, HOU Lixin, LI Shuang, CUI Yongkang, HUANG Lanwei.
Humoral immune characteristics of peripheral blood of CAP patients with antibiotic-associated DILI
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 132-135.
|
[8] |
LIU Hongliang, WANG Qing, HOU Yongfang.
Design and implementation of polypharmacy risk data management platform for common diseases of the elderly based on real world data
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1095-1098.
|
[9] |
CHU Yanqi, JIANG Yongxian, SHEN Jianghua, XING Xiaoxuan, ZHANG Qingxia, YAN Suying.
Analgesia-related risks after thoracoscopic surgery in elderly patients
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1023-1026.
|
[10] |
DONG Hanshuo, SUN Li, ZHAO Xiaoxiao, WANG Lianxin, YU Xiaokang, XIE Yanming.
Clinical characteristics and drug combination analysis of elemene injectable emulsion in the elderly in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 845-850.
|
[11] |
MA Bingbing, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian, LYU Jintao.
Consideration of rational use of traditional Chinese medicine and pharmaceutical services for the elderly based on literature analysis
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 595-599.
|
[12] |
ZHU Yuting, LI Maoxing.
One case of agranulocytosis induced by methimazole tablets
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 345-348.
|
[13] |
REN Zhao, LIU Jia, WANG Yumin, WANG Yue, XIE Qing.
Pharmaceutical care of a case of carbapenem resistant Klebsiella pneumoniae bloodstream infection treated with ceftazidime/verbatan
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1258-1261.
|
[14] |
SUN Linxi, XIE Yanming, LI Yuanyuan, SUN Menghua, LI Xiangjie.
Ways 2247 elderly patients use Lianhua Qingwen capsules in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 32-35.
|
[15] |
SUN Chunquan, XIE Yanming, HOU Hengyue.
Clinical characteristics and combined medication of Shengmai injection in the treatment of 9215 elderly patients with cardiovascular diseases
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 36-40.
|